Faculty Scholars Program

Matthew McCoy, PhD

Class of 2025
  • Assistant Professor of Medical Ethics and Health Policy
University of Pennsylvania
Scholar Project

Matthew McCoy is an Assistant Professor in the Department of Medical Ethics and Health Policy at the Perelman School of Medicine, University of Pennsylvania. He is also a senior fellow in the University of Pennsylvania’s Leonard Davis Institute of Health Economics. Dr. McCoy’s research focuses on conflicts of interest in medicine and the ethics of public engagement in health research and policy making. His Greenwall project aims to generate ethical guidance for patient organizations and disease foundations engaged in venture philanthropy, an emerging research funding model in which nonprofit organizations invest in for-profit companies.

Dr. McCoy’s work been published in medical journals including JAMA, BMJ, and the New England Journal of Medicine and bioethics journals including the American Journal of Bioethics, Bioethics, and the Journal of Medical Ethics. His research has been supported by the National Center for Advancing Translational Sciences and the Public Interest Technology University Network.

Before joining the Department of Medical Ethics and Health Policy as an assistant professor, Dr. McCoy was a postdoctoral fellow in the department from 2015 to 2017. He holds a PhD in political theory from Princeton University and a master’s degree in bioethics from the University of Pennsylvania.

For more information, visit: https://ldi.upenn.edu/fellows/fellows-directory/matthew-mccoy-phd/

Navigating Ethical Issues in Medical Venture Philanthropy

Grant Cycle: 2021 - 2022

A growing number of nonprofit patient organizations are funding medical research in both the academic and private sectors while claiming ownership stakes in the products of that research. This model of “venture philanthropy” has been hailed as a paradigm of patient-driven drug development that can spur discovery of new cures. But as mission-driven organizations act more like businesses, they must weigh the benefits of trying to accelerate medical innovation and earn financial returns against the risk that new financial entanglements will undermine their pursuit of patient interests. Amid these developments, this project will seek to generate ethical guidance for actors in this space.


Is this you? Let us know if you need to update any of this information.

BACK TO Faculty Scholars